Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Pomalidomide> ?p ?o. }
Showing items 1 to 71 of
71
with 100 items per page.
- Pomalidomide abstract "Pomalidomide (INN, originally CC-4047 or 3-amino-thalidomide, trade name Pomalyst in the US) is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide was approved in February 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma. It received a similar approval from the European Commission in August 2013, and is expected to be marketed in Europe under the brand name Imnovid.".
- Pomalidomide atcPrefix "L04".
- Pomalidomide atcSuffix "AX06".
- Pomalidomide casNumber "19171-19-8".
- Pomalidomide fdaUniiCode "D2UX06XLB5".
- Pomalidomide iupacName "4-Amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione".
- Pomalidomide pubchem "134780".
- Pomalidomide thumbnail Pomalidomide2DACS.svg?width=300.
- Pomalidomide wikiPageExternalLink results?term=pomalidomide.
- Pomalidomide wikiPageID "21507445".
- Pomalidomide wikiPageRevisionID "604724960".
- Pomalidomide atcPrefix "L04".
- Pomalidomide atcSuffix "AX06".
- Pomalidomide c "13".
- Pomalidomide casNumber "19171".
- Pomalidomide chembl "43452".
- Pomalidomide chemspiderid "118785".
- Pomalidomide eliminationHalfLife "27000.0".
- Pomalidomide excretion "Urine , faeces".
- Pomalidomide h "11".
- Pomalidomide hasPhotoCollection Pomalidomide.
- Pomalidomide inchi "1".
- Pomalidomide inchikey "UVSMNLNDYGZFPF-UHFFFAOYAO".
- Pomalidomide iupacName "4".
- Pomalidomide legalUk "POM".
- Pomalidomide legalUs "Rx-only".
- Pomalidomide licenceEu "Imnovid".
- Pomalidomide licenceUs "Pomalidomide".
- Pomalidomide metabolism "Hepatic".
- Pomalidomide molecularWeight "273.24".
- Pomalidomide n "3".
- Pomalidomide o "4".
- Pomalidomide pregnancyUs "X".
- Pomalidomide proteinBound "12".
- Pomalidomide pubchem "134780".
- Pomalidomide routesOfAdministration "Oral".
- Pomalidomide smiles "C1CCNCC1N2CC3=CCN".
- Pomalidomide stdinchi "1".
- Pomalidomide stdinchikey "UVSMNLNDYGZFPF-UHFFFAOYSA-N".
- Pomalidomide tradename "Imnovid, Pomalyst".
- Pomalidomide unii "D2UX06XLB5".
- Pomalidomide verifiedfields "changed".
- Pomalidomide verifiedrevid "352895258".
- Pomalidomide watchedfields "changed".
- Pomalidomide subject Category:Aromatic_amines.
- Pomalidomide subject Category:Glutarimides.
- Pomalidomide subject Category:Immunosuppressants.
- Pomalidomide subject Category:Orphan_drugs.
- Pomalidomide subject Category:Phthalimides.
- Pomalidomide type Agent114778436.
- Pomalidomide type CausalAgent100007347.
- Pomalidomide type Drug103247620.
- Pomalidomide type Immunosuppressant103562958.
- Pomalidomide type Immunosuppressants.
- Pomalidomide type Matter100020827.
- Pomalidomide type Medicine103740161.
- Pomalidomide type OrphanDrugs.
- Pomalidomide type PhysicalEntity100001930.
- Pomalidomide type Substance100020090.
- Pomalidomide type Drug.
- Pomalidomide type DrugProduct.
- Pomalidomide type FunctionalSubstance.
- Pomalidomide comment "Pomalidomide (INN, originally CC-4047 or 3-amino-thalidomide, trade name Pomalyst in the US) is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide was approved in February 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.".
- Pomalidomide label "Pomalidomide".
- Pomalidomide sameAs m.05h1xz7.
- Pomalidomide sameAs Q7227206.
- Pomalidomide sameAs Q7227206.
- Pomalidomide sameAs Pomalidomide.
- Pomalidomide wasDerivedFrom Pomalidomide?oldid=604724960.
- Pomalidomide depiction Pomalidomide2DACS.svg.
- Pomalidomide isPrimaryTopicOf Pomalidomide.